Tectonic Therapeutic Statistics
Total Valuation
TECX has a market cap or net worth of $316.89 million. The enterprise value is $210.12 million.
Important Dates
The last earnings date was Thursday, March 20, 2025, after market close.
| Earnings Date | Mar 20, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TECX has 18.66 million shares outstanding. The number of shares has increased by 569.30% in one year.
| Current Share Class | 18.66M |
| Shares Outstanding | 18.66M |
| Shares Change (YoY) | +569.30% |
| Shares Change (QoQ) | +0.43% |
| Owned by Insiders (%) | 36.93% |
| Owned by Institutions (%) | 35.73% |
| Float | 8.20M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.97 |
| P/TBV Ratio | 2.47 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.65, with a Debt / Equity ratio of 0.02.
| Current Ratio | 12.65 |
| Quick Ratio | 12.17 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -542.20 |
Financial Efficiency
Return on equity (ROE) is -84.79% and return on invested capital (ROIC) is -50.22%.
| Return on Equity (ROE) | -84.79% |
| Return on Assets (ROA) | -37.71% |
| Return on Invested Capital (ROIC) | -50.22% |
| Return on Capital Employed (ROCE) | -41.06% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.14M |
| Employee Count | 51 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +13.64% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +13.64% |
| 50-Day Moving Average | 30.46 |
| 200-Day Moving Average | 30.17 |
| Relative Strength Index (RSI) | 29.79 |
| Average Volume (20 Days) | 215,820 |
Short Selling Information
The latest short interest is 882,379, so 4.73% of the outstanding shares have been sold short.
| Short Interest | 882,379 |
| Short Previous Month | 944,664 |
| Short % of Shares Out | 4.73% |
| Short % of Float | 10.76% |
| Short Ratio (days to cover) | 1.44 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -58.02M |
| Pretax Income | 30.68M |
| Net Income | -57.98M |
| EBITDA | -56.37M |
| EBIT | -58.02M |
| Earnings Per Share (EPS) | -$6.83 |
Full Income StatementBalance Sheet
The company has $141.24 million in cash and $3.30 million in debt, giving a net cash position of $137.94 million or $7.39 per share.
| Cash & Cash Equivalents | 141.24M |
| Total Debt | 3.30M |
| Net Cash | 137.94M |
| Net Cash Per Share | $7.39 |
| Equity (Book Value) | 140.78M |
| Book Value Per Share | 9.48 |
| Working Capital | 135.25M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$59.08 million and capital expenditures -$156,000, giving a free cash flow of -$59.24 million.
| Operating Cash Flow | -59.08M |
| Capital Expenditures | -156,000 |
| Free Cash Flow | -59.24M |
| FCF Per Share | -$3.17 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |